Genetic and metabolic risk factors for the development of complications of type II diabetes mellitus (DM)

A. Calderara, A. E. Pontiroli, L. Bonisolli

Research output: Contribution to journalArticle

Abstract

A common feature of type II diabetes is increased atherosclerosis, and coronary heart disease (CHD) is the most important cause of mortality. Microangiopathic complications are less important in type II than in type I DM. Everyday experience suggests that the complications do not affect all diabetics to the same extent, and their development often is not associated with metabolic control. This has led to suppose that the genetic background might influence the development of complications. Therefore the aim of this study was to evaluate the possible role of some genetic markers [family history (FH) of diabetes and associated diseases, chlorpropamide alcohol flush (CPAF), acetylator phenotype (AP)] and metabolic factors, in the development of late complications in type II DM.

Original languageEnglish
Pages (from-to)1491-1493
Number of pages3
JournalTransplantation Proceedings
Volume18
Issue number6
Publication statusPublished - 1986

Fingerprint

Diabetes Complications
Type 2 Diabetes Mellitus
Chlorpropamide
Type 1 Diabetes Mellitus
Genetic Markers
Coronary Disease
Atherosclerosis
Alcohols
Phenotype
Mortality
Genetic Background

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Genetic and metabolic risk factors for the development of complications of type II diabetes mellitus (DM). / Calderara, A.; Pontiroli, A. E.; Bonisolli, L.

In: Transplantation Proceedings, Vol. 18, No. 6, 1986, p. 1491-1493.

Research output: Contribution to journalArticle

@article{2bd18331f07347c18c1c7df511fe8fc3,
title = "Genetic and metabolic risk factors for the development of complications of type II diabetes mellitus (DM)",
abstract = "A common feature of type II diabetes is increased atherosclerosis, and coronary heart disease (CHD) is the most important cause of mortality. Microangiopathic complications are less important in type II than in type I DM. Everyday experience suggests that the complications do not affect all diabetics to the same extent, and their development often is not associated with metabolic control. This has led to suppose that the genetic background might influence the development of complications. Therefore the aim of this study was to evaluate the possible role of some genetic markers [family history (FH) of diabetes and associated diseases, chlorpropamide alcohol flush (CPAF), acetylator phenotype (AP)] and metabolic factors, in the development of late complications in type II DM.",
author = "A. Calderara and Pontiroli, {A. E.} and L. Bonisolli",
year = "1986",
language = "English",
volume = "18",
pages = "1491--1493",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Genetic and metabolic risk factors for the development of complications of type II diabetes mellitus (DM)

AU - Calderara, A.

AU - Pontiroli, A. E.

AU - Bonisolli, L.

PY - 1986

Y1 - 1986

N2 - A common feature of type II diabetes is increased atherosclerosis, and coronary heart disease (CHD) is the most important cause of mortality. Microangiopathic complications are less important in type II than in type I DM. Everyday experience suggests that the complications do not affect all diabetics to the same extent, and their development often is not associated with metabolic control. This has led to suppose that the genetic background might influence the development of complications. Therefore the aim of this study was to evaluate the possible role of some genetic markers [family history (FH) of diabetes and associated diseases, chlorpropamide alcohol flush (CPAF), acetylator phenotype (AP)] and metabolic factors, in the development of late complications in type II DM.

AB - A common feature of type II diabetes is increased atherosclerosis, and coronary heart disease (CHD) is the most important cause of mortality. Microangiopathic complications are less important in type II than in type I DM. Everyday experience suggests that the complications do not affect all diabetics to the same extent, and their development often is not associated with metabolic control. This has led to suppose that the genetic background might influence the development of complications. Therefore the aim of this study was to evaluate the possible role of some genetic markers [family history (FH) of diabetes and associated diseases, chlorpropamide alcohol flush (CPAF), acetylator phenotype (AP)] and metabolic factors, in the development of late complications in type II DM.

UR - http://www.scopus.com/inward/record.url?scp=0022895126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022895126&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0022895126

VL - 18

SP - 1491

EP - 1493

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 6

ER -